Savara (SVRA) Stock: Why It's Up Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $4.63, +4.04% vs the prior close of $4.45.
- Volume 1.56M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SVRA jumps 4.0% to $4.63. Closed at $4.63, +4.04% vs the prior close of $4.45. Day range $4.49–$4.70, opened at $4.53.
SVRA daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — SVRA jumps 4.0% to $4.63
- Closed at $4.63, +4.04% vs the prior close of $4.45. Day range $4.49–$4.70, opened at $4.53.
- Volume was 1.56M shares, 0.8x its 50-day average of 1.92M.
- Price is -11.2% vs its 50-day average ($5.22) and -14.9% vs its 200-day average ($5.44).
- 52-week range $3.49–$7.01; today's close sits at 32% of that range, 33.9% below the 52-week high.
Oct 16, 2026 — SVRA slides 6.1% to $4.45, a 6-month low, 5 down days in a row
- Closed at $4.45, -6.12% vs the prior close of $4.74. Day range $4.44–$4.77, opened at $4.75.
- Volume was 2.23M shares, 1.2x its 50-day average of 1.90M.
- Price is -15.1% vs its 50-day average ($5.24) and -18.3% vs its 200-day average ($5.45).
- 52-week range $3.49–$7.01; today's close sits at 27% of that range, 36.5% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — SVRA dips 0.4% to $4.74, 4 down days in a row
- Closed at $4.74, -0.42% vs the prior close of $4.76. Day range $4.72–$4.90, opened at $4.76.
- Volume was 1.69M shares, 0.9x its 50-day average of 1.90M.
- Price is -10.0% vs its 50-day average ($5.27) and -13.1% vs its 200-day average ($5.46).
- 52-week range $3.38–$7.01; today's close sits at 38% of that range, 32.3% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — SVRA dips 0.4% to $4.76, 3 down days in a row
- Closed at $4.76, -0.42% vs the prior close of $4.78. Day range $4.65–$4.82, opened at $4.71.
- Volume was 2.57M shares, 1.4x its 50-day average of 1.87M.
- Price is -9.9% vs its 50-day average ($5.28) and -12.9% vs its 200-day average ($5.46).
- 52-week range $3.36–$7.01; today's close sits at 38% of that range, 32.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — SVRA dips 1.2% to $4.78 on 2.0x normal volume
- Closed at $4.78, -1.24% vs the prior close of $4.84. Day range $4.76–$5.02, opened at $4.84.
- Volume was 3.74M shares, 2.0x its 50-day average of 1.83M — unusually heavy trading.
- Price is -9.7% vs its 50-day average ($5.30) and -12.6% vs its 200-day average ($5.47).
- 52-week range $3.35–$7.01; today's close sits at 39% of that range, 31.8% below the 52-week high.
Oct 12, 2026 — SVRA dips 1.6% to $4.84
- Closed at $4.84, -1.63% vs the prior close of $4.92. Day range $4.81–$5.00, opened at $4.93.
- Volume was 1.31M shares, 0.7x its 50-day average of 1.83M.
- Price is -8.8% vs its 50-day average ($5.31) and -11.7% vs its 200-day average ($5.48).
- 52-week range $3.35–$7.01; today's close sits at 41% of that range, 30.9% below the 52-week high.
Oct 9, 2026 — SVRA rises 1.9% to $4.92
- Closed at $4.92, +1.86% vs the prior close of $4.83. Day range $4.81–$4.97, opened at $4.82.
- Volume was 1.53M shares, 0.8x its 50-day average of 1.82M.
- Price is -7.5% vs its 50-day average ($5.32) and -10.3% vs its 200-day average ($5.49).
- 52-week range $3.35–$7.01; today's close sits at 43% of that range, 29.8% below the 52-week high.
Oct 8, 2026 — SVRA dips 1.0% to $4.83
- Closed at $4.83, -1.02% vs the prior close of $4.88. Day range $4.64–$4.92, opened at $4.85.
- Volume was 2.51M shares, 1.4x its 50-day average of 1.80M.
- Price is -9.4% vs its 50-day average ($5.33) and -12.1% vs its 200-day average ($5.50).
- 52-week range $3.34–$7.01; today's close sits at 41% of that range, 31.0% below the 52-week high.
Oct 7, 2026 — SVRA jumps 4.9% to $4.88
- Closed at $4.88, +4.95% vs the prior close of $4.65. Day range $4.69–$5.05, opened at $4.74.
- Volume was 2.41M shares, 1.4x its 50-day average of 1.78M.
- Price is -8.6% vs its 50-day average ($5.34) and -11.3% vs its 200-day average ($5.50).
- 52-week range $3.34–$7.01; today's close sits at 42% of that range, 30.3% below the 52-week high.
Oct 6, 2026 — SVRA dips 2.7% to $4.65, a 6-month low, 4 down days in a row
- Closed at $4.65, -2.72% vs the prior close of $4.78. Day range $4.60–$4.84, opened at $4.82.
- Volume was 2.29M shares, 1.3x its 50-day average of 1.81M.
- Price is -13.1% vs its 50-day average ($5.35) and -15.6% vs its 200-day average ($5.51).
- 52-week range $3.34–$7.01; today's close sits at 36% of that range, 33.6% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — SVRA dips 0.6% to $4.78, a 3-month low, 3 down days in a row
- Closed at $4.78, -0.62% vs the prior close of $4.81. Day range $4.71–$4.91, opened at $4.85.
- Volume was 2.86M shares, 1.6x its 50-day average of 1.79M.
- Price is -10.9% vs its 50-day average ($5.37) and -13.3% vs its 200-day average ($5.51).
- 52-week range $3.34–$7.01; today's close sits at 39% of that range, 31.8% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — SVRA slides 4.7% to $4.81, a 3-month low
- Closed at $4.81, -4.66% vs the prior close of $5.05. Day range $4.76–$5.16, opened at $5.10.
- Volume was 2.65M shares, 1.5x its 50-day average of 1.77M.
- Price is -10.6% vs its 50-day average ($5.38) and -12.9% vs its 200-day average ($5.52).
- 52-week range $3.34–$7.01; today's close sits at 40% of that range, 31.3% below the 52-week high.
SVRA bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Price is -11.2% vs its 50-day average — short-term trend is down.
- Price is -14.9% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $118.84M.
- Insider selling outweighs buying: 8 sales vs 0 open-market buys among the 8 most recent reported insider trades (Form 4, last 12 months).
- Share count up 18.9% in a year (dilution).
SVRA latest news & SEC filings
Every SEC filing by or about SVRA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Parker Braden C. had withheld for taxes 29,323 shares at $5.07 (≈$148.67K) on Sep 24, 2026; now holds 75,677
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 11, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$40.23M (prior year -$30.40M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.14) (loss widened vs Jun 30, 2025)
Jul 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lowrance David L sold 394,528 shares at $5.68 (≈$2.24M) on Jun 22, 2026
- Lowrance David L sold 394,528 shares at $5.68 (≈$2.24M) on Jun 22, 2026
- Lowrance David L sold 394,528 shares at $5.68 (≈$2.24M) on Jun 22, 2026
- Lowrance David L sold 394,528 shares at $5.68 (≈$2.24M) on Jun 22, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 22, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Things to know before you trade SVRA
- Last results release: Aug 6, 2020 (8-K Item 2.02). Previous ones: May 7, 2020, Mar 12, 2020, Nov 7, 2019. Based on that rhythm, the next report is likely around Nov 5, 2020 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.31% (largest 6.1%).
- Liquidity: about 2.60M shares (≈$12.06M) trade per day on average.
- 52-week position: $4.63 vs a range of $3.49–$7.01 (32% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 8 sales; latest: David L Lowrance sold 394,528 shares on Jun 22, 2026.
- Latest filings: 10-Q Aug 11, 2026; 8-K Jun 8, 2026; 10-Q May 12, 2026.
- Share count: 205.46M shares outstanding (Aug 11, 2026), +18.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
SVRA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 4.53 | 4.70 | 4.49 | 4.63 | 1.56M |
| Oct 16, 2026 | 4.75 | 4.77 | 4.44 | 4.45 | 2.23M |
| Oct 15, 2026 | 4.76 | 4.90 | 4.72 | 4.74 | 1.69M |
| Oct 14, 2026 | 4.71 | 4.82 | 4.65 | 4.76 | 2.57M |
| Oct 13, 2026 | 4.84 | 5.02 | 4.76 | 4.78 | 3.74M |
| Oct 12, 2026 | 4.93 | 5.00 | 4.81 | 4.84 | 1.31M |
| Oct 9, 2026 | 4.82 | 4.97 | 4.81 | 4.92 | 1.53M |
| Oct 8, 2026 | 4.85 | 4.92 | 4.64 | 4.83 | 2.51M |
| Oct 7, 2026 | 4.74 | 5.05 | 4.69 | 4.88 | 2.41M |
| Oct 6, 2026 | 4.82 | 4.84 | 4.60 | 4.65 | 2.29M |
| Oct 5, 2026 | 4.85 | 4.91 | 4.71 | 4.78 | 2.86M |
| Oct 2, 2026 | 5.10 | 5.16 | 4.76 | 4.81 | 2.65M |
| Oct 1, 2026 | 5.15 | 5.24 | 5.03 | 5.05 | 2.55M |
| Sep 30, 2026 | 5.15 | 5.24 | 5.05 | 5.16 | 6.05M |
| Sep 29, 2026 | 5.07 | 5.19 | 5.00 | 5.08 | 2.03M |
| Sep 28, 2026 | 4.97 | 5.16 | 4.86 | 5.07 | 4.37M |
| Sep 25, 2026 | 5.08 | 5.18 | 4.87 | 5.00 | 2.45M |
| Sep 24, 2026 | 5.03 | 5.09 | 4.88 | 5.07 | 2.50M |
| Sep 23, 2026 | 5.30 | 5.34 | 4.90 | 5.00 | 3.35M |
| Sep 22, 2026 | 5.52 | 5.53 | 5.29 | 5.30 | 1.41M |
About Savara
Savara (SVRA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in AUSTIN, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1160308.
SVRA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Nevan C Elam | Director | Dec 11, 2025 |
| Richard J Hawkins | Director | Dec 11, 2025 |
| Joseph S Mccracken | Director | Feb 17, 2026 |
| Matthew Pauls | CHIEF EXECUTIVE OFFICER | Dec 16, 2025 |
| David A Ramsay | Director | Dec 19, 2025 |
| Es-Johansson An Van | Director | Dec 11, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Anne Erickson | Chief Business Officer | Dec 16, 2025 |
| David L Lowrance | Chief Financial Officer | Jun 22, 2026 |
| Robert Matthew Lutz | Chief Fin. & Operating Officer | Jul 24, 2026 |
| Kathleen R. Mccabe | Chief Legal Officer | Dec 16, 2025 |
| Braden C. Parker | Chief Commercial Officer | Sep 25, 2026 |
| Matthew Pauls | CHIEF EXECUTIVE OFFICER | Dec 16, 2025 |
| Yasmine Wasfi | Chief Medical Officer | Dec 4, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 22, 2026 | David L Lowrance | Sale | 394,528 | $5.68 |
| Jun 22, 2026 | David L Lowrance | Sale | 394,528 | $5.68 |
| Jun 22, 2026 | David L Lowrance | Sale | 394,528 | $5.68 |
| Jun 22, 2026 | David L Lowrance | Sale | 394,528 | $5.68 |
| Dec 19, 2025 | David A Ramsay | Sale | 20,000 | $6.06 |
| Dec 19, 2025 | David A Ramsay | Sale | 20,000 | $6.06 |
| Dec 19, 2025 | David A Ramsay | Sale | 20,000 | $6.06 |
| Dec 19, 2025 | David A Ramsay | Sale | 20,000 | $6.06 |
SVRA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-118.84M | -0.53 | $-101.04M |
| Dec 31, 2024 | — | $-95.88M | -0.48 | $-89.09M |
| Dec 31, 2023 | — | $-54.70M | -0.33 | $-51.06M |
| Dec 31, 2022 | — | $-38.15M | -0.25 | $-34.55M |
| Dec 31, 2021 | — | $-43.01M | -0.32 | $-40.08M |
Latest balance sheet: total assets $192.14M, total liabilities $48.48M, cash $41.80M (as of Jun 30, 2026).
SVRA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2020 | 8-K Item 2.02 (results) | — |
| May 7, 2020 | 8-K Item 2.02 (results) | — |
| Mar 12, 2020 | 8-K Item 2.02 (results) | — |
| Nov 7, 2019 | 8-K Item 2.02 (results) | — |
| Aug 8, 2019 | 8-K Item 2.02 (results) | — |
| May 9, 2019 | 8-K Item 2.02 (results) | — |
| Mar 13, 2019 | 8-K Item 2.02 (results) | — |
| Nov 7, 2018 | 8-K Item 2.02 (results) | — |
| Aug 9, 2018 | 8-K Item 2.02 (results) | — |
| May 9, 2018 | 8-K Item 2.02 (results) | — |
| Mar 14, 2018 | 8-K Item 2.02 (results) | — |
| Nov 8, 2017 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on SVRA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.